Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 837 entries
Sorted by: Best Match Show Resources per page
Distribution of hepatitis C virus genotypes in Iranian chronic infected patients.

Hepatitis monthly

Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F.
PMID: 23550108
Hepat Mon. 2013 Jan;13(1):e7991. doi: 10.5812/hepatmon.7991. Epub 2013 Jan 20.

BACKGROUND: Hepatitis C virus (HCV) has different genotypes throughout the world. Since the determination of which antiviral treatment to be applied is related to HCV genotypes, identification of an individual's HCV genotypes prior to antiviral therapy is critical.OBJECTIVES: The...

Cite
Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, et al. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013;13(1):e7991doi: 10.5812/hepatmon.7991.
Jahanbakhsh Sefidi, F., Keyvani, H., Monavari, S. H., Alavian, S. M., Fakhim, S., & Bokharaei-Salim, F. (2013). Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepatitis monthly, 13(1), e7991. https://doi.org/10.5812/hepatmon.7991
Jahanbakhsh Sefidi, Fatemeh, et al. "Distribution of hepatitis C virus genotypes in Iranian chronic infected patients." Hepatitis monthly vol. 13,1 (2013): e7991. doi: https://doi.org/10.5812/hepatmon.7991
Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013 Jan;13(1):e7991. doi: 10.5812/hepatmon.7991. Epub 2013 Jan 20. PMID: 23550108; PMCID: PMC3582303.
Copy Download .nbib Format: NLM
Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers.

Hepatitis monthly

Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM.
PMID: 26977171
Hepat Mon. 2015 Dec 29;15(12):e35238. doi: 10.5812/hepatmon.35238. eCollection 2015 Dec.

CONTEXT: Hepatitis A virus (HAV) infection is an important public health problem. It is estimated that about 1.4 million cases of HAV infection occur every year worldwide. Non-immune healthcare workers (HCWs) can be at higher risk of HAV infection...

Cite
Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, et al. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015;15(12):e35238doi: 10.5812/hepatmon.35238.
Rezaee-Zavareh, M. S., Karimi-Sari, H., Dolatimehr, F., & Alavian, S. M. (2015). Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepatitis monthly, 15(12), e35238. https://doi.org/10.5812/hepatmon.35238
Rezaee-Zavareh, Mohammad Saeid, et al. "Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers." Hepatitis monthly vol. 15,12 (2015): e35238. doi: https://doi.org/10.5812/hepatmon.35238
Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015 Dec 29;15(12):e35238. doi: 10.5812/hepatmon.35238. eCollection 2015 Dec. PMID: 26977171; PMCID: PMC4779254.
Copy Download .nbib Format: NLM
Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis.

Hepatitis monthly

Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM.
PMID: 27274353
Hepat Mon. 2016 Apr 19;16(4):e35558. doi: 10.5812/hepatmon.35558. eCollection 2016 Apr.

CONTEXT: Hepatitis C virus (HCV) infection is a major global public health issue. The Eastern Mediterranean regional office (EMRO) of the world health organization (WHO) seems to have one of the highest prevalence rates worldwide, with at least 21.3...

Cite
Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, et al. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepat Mon. 2016;16(4):e35558doi: 10.5812/hepatmon.35558.
Sadeghi, F., Salehi-Vaziri, M., Almasi-Hashiani, A., Gholami-Fesharaki, M., Pakzad, R., & Alavian, S. M. (2016). Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepatitis monthly, 16(4), e35558. https://doi.org/10.5812/hepatmon.35558
Sadeghi, Farzin, et al. "Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis." Hepatitis monthly vol. 16,4 (2016): e35558. doi: https://doi.org/10.5812/hepatmon.35558
Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian SM. Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis. Hepat Mon. 2016 Apr 19;16(4):e35558. doi: 10.5812/hepatmon.35558. eCollection 2016 Apr. PMID: 27274353; PMCID: PMC4894080.
Copy Download .nbib Format: NLM
Protective effect of salep on liver.

Hepatitis monthly

Pourahmad M, Kargar Jahromi H, Kargar Jahromi Z.
PMID: 26034505
Hepat Mon. 2015 Apr 25;15(4):e28137. doi: 10.5812/hepatmon.15(4)2015.28137. eCollection 2015 Apr.

BACKGROUND: Salep is used for various purposes in food industries and traditional medicine. Therefore, evaluation of its effect on the liver seems to be necessary.OBJECTIVES: The aim of this study was to assess salep effect on liver.MATERIALS AND METHODS:...

Cite
Pourahmad M, Kargar Jahromi H, Kargar Jahromi Z. Protective effect of salep on liver. Hepat Mon. 2015;15(4):e28137doi: 10.5812/hepatmon.15(4)2015.28137.
Pourahmad, M., Kargar Jahromi, H., & Kargar Jahromi, Z. (2015). Protective effect of salep on liver. Hepatitis monthly, 15(4), e28137. https://doi.org/10.5812/hepatmon.15(4)2015.28137
Pourahmad, Morteza, et al. "Protective effect of salep on liver." Hepatitis monthly vol. 15,4 (2015): e28137. doi: https://doi.org/10.5812/hepatmon.15(4)2015.28137
Pourahmad M, Kargar Jahromi H, Kargar Jahromi Z. Protective effect of salep on liver. Hepat Mon. 2015 Apr 25;15(4):e28137. doi: 10.5812/hepatmon.15(4)2015.28137. eCollection 2015 Apr. PMID: 26034505; PMCID: PMC4449893.
Copy Download .nbib Format: NLM
S gene mutants occurrence among hepatitis B carriers in malaysia.

Hepatitis monthly

Suppiah J, Mohd Zain R, Bahari N, Haji Nawi S, Saat Z.
PMID: 25737728
Hepat Mon. 2014 Nov 30;14(12):e22565. doi: 10.5812/hepatmon.22565. eCollection 2014 Dec.

BACKGROUND: The S gene region of the hepatitis B virus (HBV) codes for surface antigen (HBs Ag) and is responsible for classification of HBV strains.OBJECTIVES: The current study aimed to identify important mutations in the S gene in Hepatitis...

Cite
Suppiah J, Mohd Zain R, Bahari N, et al. S gene mutants occurrence among hepatitis B carriers in malaysia. Hepat Mon. 2014;14(12):e22565doi: 10.5812/hepatmon.22565.
Suppiah, J., Mohd Zain, R., Bahari, N., Haji Nawi, S., & Saat, Z. (2014). S gene mutants occurrence among hepatitis B carriers in malaysia. Hepatitis monthly, 14(12), e22565. https://doi.org/10.5812/hepatmon.22565
Suppiah, Jeyanthi, et al. "S gene mutants occurrence among hepatitis B carriers in malaysia." Hepatitis monthly vol. 14,12 (2014): e22565. doi: https://doi.org/10.5812/hepatmon.22565
Suppiah J, Mohd Zain R, Bahari N, Haji Nawi S, Saat Z. S gene mutants occurrence among hepatitis B carriers in malaysia. Hepat Mon. 2014 Nov 30;14(12):e22565. doi: 10.5812/hepatmon.22565. eCollection 2014 Dec. PMID: 25737728; PMCID: PMC4329239.
Copy Download .nbib Format: NLM
Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection.

Hepatitis monthly

Bokharaei-Salim F, Keyvani H, Monavari SH, Esghaei M, Fakhim S, Ataei Pirkooh A, Behnava B.
PMID: 25685166
Hepat Mon. 2014 Dec 09;14(12):e25105. doi: 10.5812/hepatmon.25105. eCollection 2014 Dec.

BACKGROUND: Hepatitis B virus (HBV) has been classified into ten genotypes (A-J) based on genome sequence divergence, which is very important for etiological and clinical investigations. HBV genotypes have distinct geographical distributions worldwide.OBJECTIVES: The aim of this study was...

Cite
Bokharaei-Salim F, Keyvani H, Monavari SH, et al. Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection. Hepat Mon. 2014;14(12):e25105doi: 10.5812/hepatmon.25105.
Bokharaei-Salim, F., Keyvani, H., Monavari, S. H., Esghaei, M., Fakhim, S., Ataei Pirkooh, A., & Behnava, B. (2014). Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection. Hepatitis monthly, 14(12), e25105. https://doi.org/10.5812/hepatmon.25105
Bokharaei-Salim, Farah, et al. "Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection." Hepatitis monthly vol. 14,12 (2014): e25105. doi: https://doi.org/10.5812/hepatmon.25105
Bokharaei-Salim F, Keyvani H, Monavari SH, Esghaei M, Fakhim S, Ataei Pirkooh A, Behnava B. Distribution of hepatitis B virus genotypes in azerbaijani patients with chronic hepatitis B infection. Hepat Mon. 2014 Dec 09;14(12):e25105. doi: 10.5812/hepatmon.25105. eCollection 2014 Dec. PMID: 25685166; PMCID: PMC4310019.
Copy Download .nbib Format: NLM
The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Hepatitis monthly

Babanejad M, Izadi N, Najafi F, Alavian SM.
PMID: 27226804
Hepat Mon. 2016 Mar 26;16(3):e35664. doi: 10.5812/hepatmon.35664. eCollection 2016 Mar.

CONTEXT: The world health organization (WHO) recommends that all blood donations should be screened for evidence of infections, such as hepatitis B. The present study aimed to determine the prevalence of hepatitis B surface antigen (HBsAg) in blood donors...

Cite
Babanejad M, Izadi N, Najafi F, et al. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon. 2016;16(3):e35664doi: 10.5812/hepatmon.35664.
Babanejad, M., Izadi, N., Najafi, F., & Alavian, S. M. (2016). The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepatitis monthly, 16(3), e35664. https://doi.org/10.5812/hepatmon.35664
Babanejad, Mehran, et al. "The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis." Hepatitis monthly vol. 16,3 (2016): e35664. doi: https://doi.org/10.5812/hepatmon.35664
Babanejad M, Izadi N, Najafi F, Alavian SM. The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon. 2016 Mar 26;16(3):e35664. doi: 10.5812/hepatmon.35664. eCollection 2016 Mar. PMID: 27226804; PMCID: PMC4875562.
Copy Download .nbib Format: NLM
Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Hepatitis monthly

Alavian SM, Haghbin H.
PMID: 27226803
Hepat Mon. 2016 Mar 06;16(3):e35106. doi: 10.5812/hepatmon.35106. eCollection 2016 Mar.

CONTEXT: Hepatocellular carcinoma (HCC) is the second most common cancer-related death worldwide. Although many factors including dietary aflatoxin B1 (AFB1) and alcoholic and non-alcoholic fatty liver diseases can lead to HCC, globally most HCC cases are due to hepatitis...

Cite
Alavian SM, Haghbin H. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Hepat Mon. 2016;16(3):e35106doi: 10.5812/hepatmon.35106.
Alavian, S. M., & Haghbin, H. (2016). Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Hepatitis monthly, 16(3), e35106. https://doi.org/10.5812/hepatmon.35106
Alavian, Seyed Moayed, and Haghbin, Hossein. "Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review." Hepatitis monthly vol. 16,3 (2016): e35106. doi: https://doi.org/10.5812/hepatmon.35106
Alavian SM, Haghbin H. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Hepat Mon. 2016 Mar 06;16(3):e35106. doi: 10.5812/hepatmon.35106. eCollection 2016 Mar. PMID: 27226803; PMCID: PMC4875504.
Copy Download .nbib Format: NLM
Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis.

Hepatitis monthly

Montesano C, Giovanetti M, Ciotti M, Cella E, Lo Presti A, Grifoni A, Zehender G, Angeletti S, Ciccozzi M.
PMID: 27226798
Hepat Mon. 2016 Mar 12;16(3):e31951. doi: 10.5812/hepatmon.31951. eCollection 2016 Mar.

BACKGROUND: Hepatitis E virus (HEV), a major cause of acute viral hepatitis in developing countries, has been classified into four main genotypes and a number of subtypes. New genotypes have been recently identified in various mammals, including HEV genotype...

Cite
Montesano C, Giovanetti M, Ciotti M, et al. Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis. Hepat Mon. 2016;16(3):e31951doi: 10.5812/hepatmon.31951.
Montesano, C., Giovanetti, M., Ciotti, M., Cella, E., Lo Presti, A., Grifoni, A., Zehender, G., Angeletti, S., & Ciccozzi, M. (2016). Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis. Hepatitis monthly, 16(3), e31951. https://doi.org/10.5812/hepatmon.31951
Montesano, Carla, et al. "Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis." Hepatitis monthly vol. 16,3 (2016): e31951. doi: https://doi.org/10.5812/hepatmon.31951
Montesano C, Giovanetti M, Ciotti M, Cella E, Lo Presti A, Grifoni A, Zehender G, Angeletti S, Ciccozzi M. Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis. Hepat Mon. 2016 Mar 12;16(3):e31951. doi: 10.5812/hepatmon.31951. eCollection 2016 Mar. PMID: 27226798; PMCID: PMC4875568.
Copy Download .nbib Format: NLM
Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.

Hepatitis monthly

Pradat P, Virlogeux V, Maynard M, Leclercq M, Hatu G, Amiri M, Lebosse F, Miailhes P, Zoulim F, Gagnieu MC, Bailly F.
PMID: 26500683
Hepat Mon. 2015 Sep 01;15(9):e28879. doi: 10.5812/hepatmon.28879. eCollection 2015 Sep.

BACKGROUND: Anemia is more frequent in patients receiving telaprevir with PEGylated interferon/ribavirin (PEG-IFN/RBV) than in those receiving PEG-IFN/RBV alone.OBJECTIVES: The objective was to measure the impact of telaprevir on RBV bioavailability and to assess the concomitant renal function.MATERIALS AND...

Cite
Pradat P, Virlogeux V, Maynard M, et al. Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy. Hepat Mon. 2015;15(9):e28879doi: 10.5812/hepatmon.28879.
Pradat, P., Virlogeux, V., Maynard, M., Leclercq, M., Hatu, G., Amiri, M., Lebosse, F., Miailhes, P., Zoulim, F., Gagnieu, M. C., & Bailly, F. (2015). Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy. Hepatitis monthly, 15(9), e28879. https://doi.org/10.5812/hepatmon.28879
Pradat, Pierre, et al. "Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy." Hepatitis monthly vol. 15,9 (2015): e28879. doi: https://doi.org/10.5812/hepatmon.28879
Pradat P, Virlogeux V, Maynard M, Leclercq M, Hatu G, Amiri M, Lebosse F, Miailhes P, Zoulim F, Gagnieu MC, Bailly F. Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy. Hepat Mon. 2015 Sep 01;15(9):e28879. doi: 10.5812/hepatmon.28879. eCollection 2015 Sep. PMID: 26500683; PMCID: PMC4611953.
Copy Download .nbib Format: NLM
Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.

Hepatitis monthly

Fouad SA, Mohamed NA, Fawzy MW, Moustafa DA.
PMID: 26500684
Hepat Mon. 2015 Sep 01;15(9):e30753. doi: 10.5812/hepatmon.30753. eCollection 2015 Sep.

BACKGROUND: Osteopontin (OPN) is a secreted glycoprotein and is frequently associated with various tumors.OBJECTIVES: We sought to investigate the clinical usefulness of the level of plasma OPN, compared to α-fetoprotein (AFP), as a biomarker for hepatocellular carcinoma (HCC) and...

Cite
Fouad SA, Mohamed NA, Fawzy MW, et al. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. Hepat Mon. 2015;15(9):e30753doi: 10.5812/hepatmon.30753.
Fouad, S. A., Mohamed, N. A., Fawzy, M. W., & Moustafa, D. A. (2015). Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. Hepatitis monthly, 15(9), e30753. https://doi.org/10.5812/hepatmon.30753
Fouad, Shawky Abdelhamid, et al. "Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma." Hepatitis monthly vol. 15,9 (2015): e30753. doi: https://doi.org/10.5812/hepatmon.30753
Fouad SA, Mohamed NA, Fawzy MW, Moustafa DA. Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma. Hepat Mon. 2015 Sep 01;15(9):e30753. doi: 10.5812/hepatmon.30753. eCollection 2015 Sep. PMID: 26500684; PMCID: PMC4612688.
Copy Download .nbib Format: NLM
Geographic distribution of hepatitis C virus genotypes in pakistan.

Hepatitis monthly

Khan N, Akmal M, Hayat M, Umar M, Ullah A, Ahmed I, Rahim K, Ali S, Bahadar S, Saleha S.
PMID: 25477975
Hepat Mon. 2014 Oct 11;14(10):e20299. doi: 10.5812/hepatmon.20299. eCollection 2014 Oct.

BACKGROUND: Distribution of Hepatitis C Virus (HCV) genotypes may be changed over time. Epidemiological Studies on distribution patterns of HCV genotypes in Pakistani population might assist for better treatment options and preventive strategies.OBJECTIVES: This study was conducted to determine...

Cite
Khan N, Akmal M, Hayat M, et al. Geographic distribution of hepatitis C virus genotypes in pakistan. Hepat Mon. 2014;14(10):e20299doi: 10.5812/hepatmon.20299.
Khan, N., Akmal, M., Hayat, M., Umar, M., Ullah, A., Ahmed, I., Rahim, K., Ali, S., Bahadar, S., & Saleha, S. (2014). Geographic distribution of hepatitis C virus genotypes in pakistan. Hepatitis monthly, 14(10), e20299. https://doi.org/10.5812/hepatmon.20299
Khan, Nasar, et al. "Geographic distribution of hepatitis C virus genotypes in pakistan." Hepatitis monthly vol. 14,10 (2014): e20299. doi: https://doi.org/10.5812/hepatmon.20299
Khan N, Akmal M, Hayat M, Umar M, Ullah A, Ahmed I, Rahim K, Ali S, Bahadar S, Saleha S. Geographic distribution of hepatitis C virus genotypes in pakistan. Hepat Mon. 2014 Oct 11;14(10):e20299. doi: 10.5812/hepatmon.20299. eCollection 2014 Oct. PMID: 25477975; PMCID: PMC4250967.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 837 entries